
    
      Treatment of the study is a single daily fixed-hour (21h) dose of 15 mL of an oral syrup, at
      one of the 3 following concentrations of melatonin: 0 mg/ml i.e. 0 mg/day (placebo); 0.02
      mg/ml, i.e. 0.3 mg/day (low dose of melatonin) or 0.2 mg/ml, i.e. 3 mg/day (high dose of
      melatonin). The three dosages will be identical in appearance and volume.Treatment will be
      administered up to Day-14 (or death or discharge if these occur before Day-14). Randomization
      will be stratified by center.
    
  